Market Overview

Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Share:
Related TRIB
Earnings Scheduled For March 14, 2017
10 Stocks With Highest Close In Three Weeks
Related VIVO
15 Biggest Mid-Day Losers For Wednesday
Mid-Afternoon Market Update: Seagate Climbs On Strong Q2 Results; Meridian Bioscience Shares Plummet
Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to ... (GuruFocus)

Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.71%. Trinity Biotech's revenue for the same period is $81.70 million.

The trailing-twelve-month profit margin at Meridian Bioscience (NASDAQ: VIVO) is 19.23%. Meridian Bioscience's ROA for the same period is 19.85%.

The trailing-twelve-month profit margin at IDEXX Laboratories (NASDAQ: IDXX) is 13.50%. IDEXX Laboratories' ROE for the same period is 28.74%.

The trailing-twelve-month profit margin at Neogen (NASDAQ: NEOG) is 12.78%. Neogen's PEG ratio is 2.19.

Posted-In: Diagnostic Substances Industry Highest Profit Margin NASDAQ StocksTrading Ideas

 

Related Articles (IDXX + NEOG)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...